Genmab — Juni 2020

[gdn55]

Jo, eller barsel

[E_L]

@kkjoel so you were right; it was 15

[E_L]

Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma

Company Announcement Subcutaneous fixed-dosed formulation of DARZALEX® (daratumumab) approved in Europe for the treatment of adult patients with multiple...

GlobeNewswire News Room (www.globenewswire.com)

[kkjoel]

Yup, it sure sounded like that.. men 15 eller 50.. tomatos-tomaaatos

[E_L]

European Marketing Authorization for the Subcutaneous Formulation of DARZALEX

[E_L]

lol

[kkjoel]

:-9

[kkjoel]

Der kom den sgu - den europæiske dara sc!

[E_L]

that is pretty fast , no? just over 1 month to confirm CHMP opinio

[E_L]

n

[Bulder]

Stod der noget godt i den Børsen-artikel?

[kkjoel]

Den er baseret på fireside chatten forleden - det er de samme opl.

[kkjoel]

Og ja, masser af godter..

[kkjoel]

Omkring Duobody teknologien. Men vist alt sammen kendt i forvejen.

[kkjoel]

Bortset altså fra den der med "15 gange bedre end Hemlibra". Han skal vel spørges næste gang om på hvilken måde den er 15 gange bedre..

[kkjoel]

Ja, vi taler jo Mime8 - deres nye Duobody bløderstof.

[Bulder]

tak

[E_L]

i reckon 1 month earlier approval for SC is worth a lot more as the 3 month delay for Ofa...

[concillado]

Agreed EL. On month earlier possibility of income!

[concillado]

*one